Neonates and Medicines: A Roadmap to Further Improve Neonatal Pharmaceutical Care
The treatment of newborns with safe and effective medicines is of critical importance for their outcome and subsequent quality of life. Despite this, it is still a common practice to prescribe medicines to neonates outside the label, extrapolating from dosing regimens and indications validated in older populations and based on non-neonatal pathophysiology. In a recent meta-analysis (2015) evaluating 829 (1994–2012) studies on prescribing practices in pediatric hospital care, off-label and unlicensed medicines prescriptions ranged from 12 to 71 % and 0.2 to 48 %. These authors hereby reconfirmed that (pre)term neonates were still most commonly exposed to off-label and unlicensed medicines .
& Sherwin, C. M.
(2016). Neonates and Medicines: A Roadmap to Further Improve Neonatal Pharmaceutical Care. European Journal of Pediatrics, 175 (6), 743-746.